Adamis Pharmaceuticals names co-founder David Marguglio as CEO
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
-100,00%
Echtzeit-Aktienkurs Adamis Pharmaceuticals Corp.
Bid:
Ask:
Nachrichten zur Adamis Pharmaceuticals Corp. Aktie
Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and Growth
David J. Marguglio, Co-Founder and Chief Business Officer, Appointed President and CEO...…
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET Management to host webcast/conference call today…
Form 10-K/A Adamis Pharmaceuticals For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals: Preparing For Another Round Of Success, Failure, Then Hope
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Adamis Pharmaceuticals For: Apr 07
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-K Adamis Pharmaceuticals For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET Management to host webcast/conference call today…
US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone Product
High-Dose Naloxone Now Available to Help Combat the Growing Epidemic of Overdose Deaths High-Dose Naloxone Now Available to Help Combat…
Form 8-K Adamis Pharmaceuticals For: Mar 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Adamis Pharmaceuticals im Wert von 4.949$
Moss, Ronald B. - Vorstand - Tag der Transaktion: 2022-03-18...…
Insiderhandel: Chief Financial Officer verkauft Aktien von Adamis Pharmaceuticals im Wert von 2.208$
Benedicto, David C. - Vorstand - Tag der Transaktion: 2022-03-18...…
Insiderhandel: SVP and Chief Business Officer verkauft Aktien von Adamis Pharmaceuticals im Wert von 7.117$
Marguglio, David J. - Vorstand - Tag der Transaktion: 2022-03-18...…
Insiderhandel: President & CEO verkauft Aktien von Adamis Pharmaceuticals im Wert von 6.287$
Carlo, Dennis J Phd - Vorstand - Tag der Transaktion: 2022-03-18...…
Adamis Pharma Recalls Allergy Treatment Symjepi For Potential Manufacturing Defect
read more...…
Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing Defect
SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of…
Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19
DSMB met to evaluate interim clinical and safety data and clears Phase 2/3 study to continue DSMB met to evaluate…
Adamis pharmaceuticals chairman to retire
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals Announces Retirement of Richard C. Williams, Chairman of the Board
SAN DIEGO, March 04, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), today announced the retirement of…
Form 8-K Adamis Pharmaceuticals For: Feb 25
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Adamis Pharmaceuticals For: Feb 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Announces Inducement Option Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a specialty biopharmaceutical company primarily…
Adamis Pharmaceuticals Provides Enrollment Update of Subjects in Phase 2/3 Study of Tempol for the Treatment of COVID-19
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the enrollment and dosing…
Thinking about buying stock in Pluristem Therapeutics, DiDi Global, Robinhood Markets, Bitfarms, or Adamis Pharmaceuticals?
NEW YORK, Jan. 10, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PSTI, DIDI, HOOD, BITF, and ADMP. To…
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the submission of a…
Form 8-K Adamis Pharmaceuticals For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is the Options Market Predicting a Spike in Adamis Pharmaceuticals (ADMP) Stock?
Investors need to pay close attention to Adamis Pharmaceuticals (ADMP) stock based on the movements in the options market lately....…
Adamis Pharmaceuticals Updates Comparative Pharmacology Model Data Supporting the Higher 5 mg Intramuscular Dose of Naloxone in ZIMHI™
Drug overdoses are the leading cause of death for those under age 50 Drug overdoses are the leading cause of…
Adamis Pharmaceuticals regains Nasdaq compliance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing Requirements
SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and…
Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q3 2021 Result - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals EPS misses by $0.07, misses on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET Management to host webcast/conference call today…
Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business Update
SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and…
Global Auto-Injector Market Outlook Report 2021-2030 Featuring Pfizer, BD, Adamis Pharma, Biogen, Teva Pharma, Mylan, Antares Pharma, Sanofi, Ypsomed, & SHL Medical
DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Global Auto Injector Market Outlook 2030" report has been added to ResearchAndMarkets.coms offering.…
Thinking about buying stock in Progenity, Atea Pharmaceuticals, Peabody Energy, Adamis Pharmaceuticals, or Ion Geophysical?
NEW YORK, Oct. 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, AVIR, BTU, ADMP, and IO. To…
Adamis Pharma Shares Rise 16% After FDA Approves Zimhi for Opioid Overdose
Adamis Pharma Shares Rise 16% After FDA Approves Zimhi for Opioid Overdose...…
Adamis Pharma Stock Jumps as FDA Clears Opioid-Overdose Treatment
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals stock rockets on heavy volume after opioid overdose treatment gets FDA approval
Shares of Adamis Pharmaceuticals Corp. soared 20.4% on massive volume toward an eight-month high in premarket trading Monday, after…
Adamis shares surge more than 42% after FDA approves opioid overdose treatment ZIMHI
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals Gets FDA Approval for Zimhi Injection Product
Adamis Pharmaceuticals Gets FDA Approval for Zimhi Injection Product...…
Adamis Receives FDA Approval for ZIMHI
New High-Dose Naloxone Product for the Treatment of Opioid Overdose New High-Dose Naloxone Product for the Treatment of Opioid Overdose...…
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
Appointment of New Director with Significant Experience in Drug Development, Licensing and Commercialization Appointment of New Director with Significant Experience…
Adamis Pharmaceuticals Corp: 8-K Report
CURRENT REPORT...…
Adamis (ADMP) Begins Dosing in COVID Oral Antiviral Study
Adamis (ADMP) starts dosing patients in phase II/III study to evaluate its oral investigational antiviral for the treatment of COVID-19....…
Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing
read more...…
Adamis Kicks Off Phase 2/3 Trial of Antiviral for Covid-19
Adamis Kicks Off Phase 2/3 Trial of Antiviral for Covid-19...…
Adamis gets dosing underway in phase 2/3 Tempol COVID-19 trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment of COVID-19
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the initiation of patient…
Adamis Pharmaceuticals Corp: 8-K Report
CURRENT REPORT...…